Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: TH1902 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for TH1902 in patients with advanced solid tumors. The study is currently active/not recruiting and …
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating pembrolizumab plus lenvatinib and chemotherapy as first-line treatment for extensive-stage small cell…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Lung Cancer Registry
A ClinicalTrials.gov registry entry for the Lung Cancer Registry (NCT04654364) shows the study is currently recruiting. The conditions inclu…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC) [Phase 2]
Phase 2 clinical trial evaluating serplulimab with chemotherapy as neoadjuvant therapy for limited-stage small cell lung cancer; recruitment…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer [Phase 2]
Phase 2 trial evaluating dose-attenuated chemotherapy in compromised patients with lung cancer is currently recruiting. The study includes b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
This clinical trial update announces ongoing recruitment for the TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO study led by Un…
-
CLINICAL_TRIALS research · 2025-03-31Clinical Trial Update: SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
The document reports a not-yet-recruiting clinical trial evaluating a SERS-based serum spectral screening method for lung cancer type differ…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Study of AZD2811 + Durvalumab in ES-SCLC [Phase 2]
A Phase 2 clinical trial evaluating the combination of AZD2811 and durvalumab for extensive-stage small cell lung cancer is active/not recru…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
This update reports the completion of a multicenter clinical trial evaluating sputum DNA testing for lung cancer in China, sponsored by Crea…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
A recruiting study evaluating genomic and methylation markers to predict resistance to chemo-immunotherapy in small cell lung cancer and lar…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]
A Phase 2 trial (QUADRUPLE THREAT) evaluated RRx-001 in small cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and epith…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating AK104 in combination with Chiauranib for extensive-stage small cell lung cancer has completed; no specific resu…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC [Phase 2]
Updates on a Phase 2 study of PM8002 (anti-PD-L1/VEGF) in combination with chemotherapy for extensive-stage small cell lung cancer, with the…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: A Multicenter Cancer Biospecimen Collection Study
A multicenter cancer biospecimen collection trial sponsored by Cofactor Genomics is currently recruiting, covering multiple cancer indicatio…
-
CLINICAL_TRIALS approval · 2025-03-10Clinical Trial Update: Tarlatamab (AMG 757) Expanded Access Protocol for Advanced Small Cell Lung Cancer
Amgen's tarlatamab (AMG 757) expanded access protocol for advanced small cell lung cancer has been approved for marketing.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of RO7616789 in advan…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors [Phase 2]
Phase 2 trial of ladiratuzumab vedotin in multiple advanced solid tumors was terminated, with results posted in March 2025.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 to standard chemotherapy for advanced solid tumors, focusing on small cell lung cancer, poorly d…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating platinum plus etoposide with or without tislelizumab in untreated extensive-stage small cell lung cancer has comp…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer. [Phase 2]
Phase 2 trial evaluating tislelizumab with chemotherapy, with or without radiotherapy, for extensive-stage oligometastatic small cell lung c…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study evaluating AL3818 in combination with nivolumab for solid tumors; the trial is currently not recr…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
A clinical trial registry entry for a platform study evaluating molecular testing, treatment, and outcomes in non-small cell lung cancer and…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Etoposide Plus Benmelstobart Followed by Maintenance Therapy of Benmelstobart Plus Anlotinib in First-line Treatment of Elderly Patients with Extensive Stage Small Cell Lung Cancer: a Single-arm, Prospective Trial
A single-arm prospective clinical trial in elderly patients with extensive-stage small cell lung cancer evaluating etoposide plus benmelstob…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer [Phase 3]
A Phase III trial evaluating YL201 for relapsed small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS other · 2025-02-11Clinical Trial Update: First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC [Phase 2]
A Phase 2 trial evaluating first-line pembrolizumab with plinabulin plus etoposide and platinum for extensive-stage small cell lung cancer i…